IOL Chemicals Announces 39th AGM on Sep 2, 2026, with E-voting Facility
IOL Chemicals and Pharmaceuticals Limited will hold its 39th Annual General Meeting on September 2, 2026, at 11:30 AM IST via video conference. The integrated annual report for FY26 has been dispatched. Remote e-voting is available from August 30 to September 1, 2026. The cut-off date for voting eligibility is August 26, 2026.
This is a standard corporate disclosure about the AGM. It does not contain any new financial results, strategic changes, or significant operational updates that would have a material impact on the company's stock.
The announcement is a routine procedural update regarding the Annual General Meeting and does not contain any new financial information or significant business developments that would impact the stock price.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has published a notice regarding its 39th Annual General Meeting (AGM), scheduled to be held on Wednesday, September 2, 2026, at 11:30 AM IST. The meeting will be conducted entirely through video conferencing (VC) and other audio-visual means, with no physical attendance permitted.
In compliance with SEBI regulations and company circulars, the AGM notice and the integrated annual report for the financial year 2025-26 were dispatched to shareholders on August 7, 2026. These documents are also available on the company's website (www.ioicp.com) and the websites of the stock exchanges (BSE and NSE), as well as on the CDSL website (www.evotingindia.com).
The company has provided a remote e-voting facility for all businesses listed in the AGM notice. The cut-off date for determining eligibility to vote is August 26, 2026. Remote e-voting will commence on August 30, 2026, at 9:00 AM and conclude on September 1, 2026, at 5:00 PM. Members can also cast their vote during the AGM itself. Detailed procedures for remote e-voting and e-voting during the AGM are available in the AGM notice. The newspaper advertisement containing this information was published on August 8, 2026, in Financial Express (English) and Punjabi Jagran (Punjabi).
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.